Note any side effects, their severity, and whether they are improving or worsening
6 The gut microbiome's influence on food preferences and metabolic signaling makes probiotic strains relevant to sugar craving support
For some patients, prescription medications can provide a powerful boost to their weight loss journey
In the SUSTAIN program, 83 patients (1.4%) treated with semaglutide developed a gallbladder event, compared with 39 patients (1.9%) in the placebo group ( versus 0.1% with placebo), while the risk of cholecystitis was similar (data derived from the summary of product characteristics (SmPC) (87), as the manuscripts did not describe these data)
Semaglutide, the active ingredient of Wegovy, is a GLP-1 receptor agonist that helps reduce appetite and regulates blood sugar levels